Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shaocong Mo
Observed names:
S Mo,
S. Mo
Institutions:
First Affiliated Hospital of Guangzhou Medical University,
State Key Laboratory of Respiratory Disease,
Guangzhou Institute of Respiratory Health,
Guangzhou Medical University
Observed institutions:
First Affiliated Hospital of Guangzhou Medical University,
First Affiliated Hospital of Xi'an Jiaotong University,
State Key Laboratory of Respiratory Disease,
Guangzhou Institute of Respiratory Health,
Xi'an Jiaotong University,
Guangzhou Medical University
show all 6
ORCID:
0009-0007-9371-8124
Observed ORCID:
0009-0007-9371-8124
OpenAlex ID:
A5113278710
Deficiency of Endothelial Piezo2 Impairs Pulmonary Vascular Angiogenesis and Predisposes Pulmonary Hypertension
2025
·
Feng Wei
, Ziying Lin
, et al.
·
Hypertension
·
27
Safety and efficacy at 1 year after switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in chronic HBV patients with risk factors for TDF use
2018
·
E. Gane
, W.-K. Seto
, et al.
·
Journal of Hepatology
·
9
Continued improvement in renal laboratory parameters in CHB patients treated with tenofovir alfenamide (TAF) compared with tenofovir disoproxil fumarate (TDF) over 96 weeks
2017
·
W.L. Chuang
, K. Agarwal
, et al.
·
Journal of Hepatology
·
7
Integrated Single-Cell Atlas Reveals Cross-Subtype Heterogeneity in Human Pulmonary Hypertension
2026
·
Huazhuo Feng
, Jiaxuan Lai
, et al.
·
Arteriosclerosis Thrombosis and Vascular Biology
·
6
Scientometric analysis of research trends in hemorrhagic fever with renal syndrome: A historical review and network visualization
2025
·
Bing Xu
, Qian Yin
, et al.
·
Journal of Infection and Public Health
·
3
Echinatin Alleviates Experimental Pulmonary Hypertension by PPARγ Pathway Activation
2026
·
Wei Feng
, Dan Bai
, et al.
·
The FASEB Journal
·
1
Correlating hemorrhagic fever with renal syndrome incidence and research publications in China: insights from epidemiological and bibliometric analysis
2025
·
Bing Xu
, Shaocong Mo
, et al.
·
One Health Outlook
·
1
PDF
Alkylating Agent–Induced FANCL Impairment Damages Pulmonary Arterial, Venous, and Microvascular Endothelial Cells and Predisposes to PAH/PVOD
2026
·
Shiyun Liu
, Yufei Sun
, et al.
·
Advanced Science
D106-16 Targeting Enterocyte PPARγ: A Novel Gut-centric Therapeutic Strategy for Pulmonary Hypertension
2026
·
K Yang
, Z Zhang
, et al.
·
American Journal of Respiratory and Critical Care Medicine
Show more works
View as search
Works count:
9
Citation count:
54
H-index:
4
I10-index:
1
Year
Topic
Type